APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cyclin Dependent Kinase 1

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cyclin Dependent Kinase 1 Market Outlook and Growth Opportunities 2026

Report ID 173981840422 December 2025199 pages

Choose your research edition.

Industry ResearchCyclin Dependent Kinase 1 Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Cyclin Dependent Kinase 1 Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Cyclin Dependent Kinase 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cyclin Dependent Kinase 1 Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Cyclin Dependent Kinase 1 Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Cyclin Dependent Kinase 1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cyclin Dependent Kinase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cyclin Dependent Kinase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cyclin Dependent Kinase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cyclin Dependent Kinase 1 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cyclin Dependent Kinase 1 market include Tragara Pharmaceuticals Inc, Tiziana Life Sciences Plc, Presage Biosciences Inc, ChoDang Pharm Co Ltd and Astex Pharmaceuticals Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cyclin Dependent Kinase 1 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cyclin Dependent Kinase 1 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cyclin Dependent Kinase 1 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cyclin Dependent Kinase 1 market size, projected growth trends, production technologies, key applications, and end-use industries.

Cyclin Dependent Kinase 1 Segment by Company

Tragara Pharmaceuticals Inc

Tiziana Life Sciences Plc

Presage Biosciences Inc

ChoDang Pharm Co Ltd

Astex Pharmaceuticals Inc

Cyclin Dependent Kinase 1 Segment by Type

Milciclib

CD-650

AT-7519

Others

Cyclin Dependent Kinase 1 Segment by Application

Relapsed Chronic Lymphocytic Leukemia

Lymphoma

Gliosarcoma

Others

Cyclin Dependent Kinase 1 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cyclin Dependent Kinase 1 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Cyclin Dependent Kinase 1 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cyclin Dependent Kinase 1 significant trends, drivers, influence factors in global and regions.

6. To analyze Cyclin Dependent Kinase 1 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyclin Dependent Kinase 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cyclin Dependent Kinase 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyclin Dependent Kinase 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cyclin Dependent Kinase 1 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cyclin Dependent Kinase 1 industry.

Chapter 3: Detailed analysis of Cyclin Dependent Kinase 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Cyclin Dependent Kinase 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Cyclin Dependent Kinase 1 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cyclin Dependent Kinase 1 Industry Trends Table 2. Cyclin Dependent Kinase 1 Industry Drivers Table 3. Cyclin Dependent Kinase 1 Industry Opportunities and Challenges Table 4. Cyclin Dependent Kinase 1 Industry Restraints Table 5. Global Cyclin Dependent Kinase 1 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cyclin Dependent Kinase 1 Revenue Share by Company (2021-2026) Table 7. Global Cyclin Dependent Kinase 1 Sales Volume by Company (k units) & (2021-2026) Table 8. Global Cyclin Dependent Kinase 1 Sales Volume Share by Company (2021-2026) Table 9. Global Cyclin Dependent Kinase 1 Average Price (US$/unit) of Company (2021-2026) Table 10. Global Cyclin Dependent Kinase 1 Company Ranking, (2024-2026) & (USD Million) Table 11. Global Cyclin Dependent Kinase 1 Key Company Manufacturing Base & Headquarters Table 12. Global Cyclin Dependent Kinase 1 Company, Product Type & Application Table 13. Global Cyclin Dependent Kinase 1 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Cyclin Dependent Kinase 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Milciclib Table 18. Significant Companies of CD-650 Table 19. Significant Companies of AT-7519 Table 20. Significant Companies of Others Table 21. Global Cyclin Dependent Kinase 1 Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Cyclin Dependent Kinase 1 Sales Volume by Type (2021-2026) & (k units) Table 23. Global Cyclin Dependent Kinase 1 Sales Volume by Type (2027-2032) & (k units) Table 24. Global Cyclin Dependent Kinase 1 Sales Volume Share by Type (2021-2026) Table 25. Global Cyclin Dependent Kinase 1 Sales Volume Share by Type (2027-2032) Table 26. Global Cyclin Dependent Kinase 1 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Cyclin Dependent Kinase 1 Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Cyclin Dependent Kinase 1 Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Cyclin Dependent Kinase 1 Sales Value Share by Type (2021-2026) Table 30. Global Cyclin Dependent Kinase 1 Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Relapsed Chronic Lymphocytic Leukemia Table 32. Significant Companies of Lymphoma Table 33. Significant Companies of Gliosarcoma Table 34. Significant Companies of Others Table 35. Global Cyclin Dependent Kinase 1 Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Cyclin Dependent Kinase 1 Sales Volume by Application (2021-2026) & (k units) Table 37. Global Cyclin Dependent Kinase 1 Sales Volume by Application (2027-2032) & (k units) Table 38. Global Cyclin Dependent Kinase 1 Sales Volume Share by Application (2021-2026) Table 39. Global Cyclin Dependent Kinase 1 Sales Volume Share by Application (2027-2032) Table 40. Global Cyclin Dependent Kinase 1 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Cyclin Dependent Kinase 1 Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Cyclin Dependent Kinase 1 Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Cyclin Dependent Kinase 1 Sales Value Share by Application (2021-2026) Table 44. Global Cyclin Dependent Kinase 1 Sales Value Share by Application (2027-2032) Table 45. Global Cyclin Dependent Kinase 1 Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Cyclin Dependent Kinase 1 Sales by Region (2021-2026) & (k units) Table 47. Global Cyclin Dependent Kinase 1 Sales Market Share by Region (2021-2026) Table 48. Global Cyclin Dependent Kinase 1 Sales by Region (2027-2032) & (k units) Table 49. Global Cyclin Dependent Kinase 1 Sales Market Share by Region (2027-2032) Table 50. Global Cyclin Dependent Kinase 1 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Cyclin Dependent Kinase 1 Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Cyclin Dependent Kinase 1 Sales Value Share by Region (2021-2026) Table 53. Global Cyclin Dependent Kinase 1 Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Cyclin Dependent Kinase 1 Sales Value Share by Region (2027-2032) Table 55. Global Cyclin Dependent Kinase 1 Market Average Price (US$/unit) by Region (2021-2026) Table 56. Global Cyclin Dependent Kinase 1 Market Average Price (US$/unit) by Region (2027-2032) Table 57. Global Cyclin Dependent Kinase 1 Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Cyclin Dependent Kinase 1 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Cyclin Dependent Kinase 1 Sales by Country (2021-2026) & (k units) Table 60. Global Cyclin Dependent Kinase 1 Sales Market Share by Country (2021-2026) Table 61. Global Cyclin Dependent Kinase 1 Sales by Country (2027-2032) & (k units) Table 62. Global Cyclin Dependent Kinase 1 Sales Market Share by Country (2027-2032) Table 63. Global Cyclin Dependent Kinase 1 Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Cyclin Dependent Kinase 1 Sales Value Market Share by Country (2021-2026) Table 65. Global Cyclin Dependent Kinase 1 Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Cyclin Dependent Kinase 1 Sales Value Market Share by Country (2027-2032) Table 67. Tragara Pharmaceuticals Inc Company Information Table 68. Tragara Pharmaceuticals Inc Business Overview Table 69. Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product Portfolio Table 71. Tragara Pharmaceuticals Inc Recent Development Table 72. Tiziana Life Sciences Plc Company Information Table 73. Tiziana Life Sciences Plc Business Overview Table 74. Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Product Portfolio Table 76. Tiziana Life Sciences Plc Recent Development Table 77. Presage Biosciences Inc Company Information Table 78. Presage Biosciences Inc Business Overview Table 79. Presage Biosciences Inc Cyclin Dependent Kinase 1 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Presage Biosciences Inc Cyclin Dependent Kinase 1 Product Portfolio Table 81. Presage Biosciences Inc Recent Development Table 82. ChoDang Pharm Co Ltd Company Information Table 83. ChoDang Pharm Co Ltd Business Overview Table 84. ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Product Portfolio Table 86. ChoDang Pharm Co Ltd Recent Development Table 87. Astex Pharmaceuticals Inc Company Information Table 88. Astex Pharmaceuticals Inc Business Overview Table 89. Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product Portfolio Table 91. Astex Pharmaceuticals Inc Recent Development Table 92. Key Raw Materials Table 93. Raw Materials Key Suppliers Table 94. Cyclin Dependent Kinase 1 Distributors List Table 95. Cyclin Dependent Kinase 1 Customers List Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Cyclin Dependent Kinase 1 Product Image Figure 2. Global Cyclin Dependent Kinase 1 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cyclin Dependent Kinase 1 Sales Value (2021-2032) & (US$ Million) Figure 4. Global Cyclin Dependent Kinase 1 Sales (2021-2032) & (k units) Figure 5. Global Cyclin Dependent Kinase 1 Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Cyclin Dependent Kinase 1 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Milciclib Image Figure 10. CD-650 Image Figure 11. AT-7519 Image Figure 12. Others Image Figure 13. Global Cyclin Dependent Kinase 1 Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Cyclin Dependent Kinase 1 Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Cyclin Dependent Kinase 1 Sales Volume Share by Type (2021-2032) Figure 16. Global Cyclin Dependent Kinase 1 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Cyclin Dependent Kinase 1 Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Cyclin Dependent Kinase 1 Sales Value Share by Type (2021-2032) Figure 19. Relapsed Chronic Lymphocytic Leukemia Image Figure 20. Lymphoma Image Figure 21. Gliosarcoma Image Figure 22. Others Image Figure 23. Global Cyclin Dependent Kinase 1 Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Cyclin Dependent Kinase 1 Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Cyclin Dependent Kinase 1 Sales Volume Share by Application (2021-2032) Figure 26. Global Cyclin Dependent Kinase 1 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Cyclin Dependent Kinase 1 Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Cyclin Dependent Kinase 1 Sales Value Share by Application (2021-2032) Figure 29. Global Cyclin Dependent Kinase 1 Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Cyclin Dependent Kinase 1 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Cyclin Dependent Kinase 1 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Cyclin Dependent Kinase 1 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Cyclin Dependent Kinase 1 Sales Value (2021-2032) & (US$ Million) Figure 34. North America Cyclin Dependent Kinase 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Cyclin Dependent Kinase 1 Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Cyclin Dependent Kinase 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Cyclin Dependent Kinase 1 Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Cyclin Dependent Kinase 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Cyclin Dependent Kinase 1 Sales Value (2021-2032) & (US$ Million) Figure 40. South America Cyclin Dependent Kinase 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Cyclin Dependent Kinase 1 Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Cyclin Dependent Kinase 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Cyclin Dependent Kinase 1 Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Cyclin Dependent Kinase 1 Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Milciclib
  • CD-650
  • AT-7519
  • Others
Applications
  • Relapsed Chronic Lymphocytic Leukemia
  • Lymphoma
  • Gliosarcoma
  • Others
Companies covered
  • Tragara Pharmaceuticals Inc
  • Tiziana Life Sciences Plc
  • Presage Biosciences Inc
  • ChoDang Pharm Co Ltd
  • Astex Pharmaceuticals Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cyclin Dependent Kinase 1 Sales Value (2021-2032)
  4. 1.2.2 Global Cyclin Dependent Kinase 1 Sales Volume (2021-2032)
  5. 1.2.3 Global Cyclin Dependent Kinase 1 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Cyclin Dependent Kinase 1 Market Dynamics
  1. 2.1 Cyclin Dependent Kinase 1 Industry Trends
  2. 2.2 Cyclin Dependent Kinase 1 Industry Drivers
  3. 2.3 Cyclin Dependent Kinase 1 Industry Opportunities and Challenges
  4. 2.4 Cyclin Dependent Kinase 1 Industry Restraints
3 Cyclin Dependent Kinase 1 Market by Company
  1. 3.1 Global Cyclin Dependent Kinase 1 Company Revenue Ranking in 2025
  2. 3.2 Global Cyclin Dependent Kinase 1 Revenue by Company (2021-2026)
  3. 3.3 Global Cyclin Dependent Kinase 1 Sales Volume by Company (2021-2026)
  4. 3.4 Global Cyclin Dependent Kinase 1 Average Price by Company (2021-2026)
  5. 3.5 Global Cyclin Dependent Kinase 1 Company Ranking (2024-2026)
  6. 3.6 Global Cyclin Dependent Kinase 1 Company Manufacturing Base and Headquarters
  7. 3.7 Global Cyclin Dependent Kinase 1 Company Product Type and Application
  8. 3.8 Global Cyclin Dependent Kinase 1 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Cyclin Dependent Kinase 1 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Cyclin Dependent Kinase 1 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Cyclin Dependent Kinase 1 Market by Type
  1. 4.1 Cyclin Dependent Kinase 1 Type Introduction
  2. 4.1.1 Milciclib
  3. 4.1.2 CD-650
  4. 4.1.3 AT-7519
  5. 4.1.4 Others
  6. 4.2 Global Cyclin Dependent Kinase 1 Sales Volume by Type
  7. 4.2.1 Global Cyclin Dependent Kinase 1 Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Cyclin Dependent Kinase 1 Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Cyclin Dependent Kinase 1 Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Cyclin Dependent Kinase 1 Sales Value by Type
  11. 4.3.1 Global Cyclin Dependent Kinase 1 Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Cyclin Dependent Kinase 1 Sales Value by Type (2021-2032)
  13. 4.3.3 Global Cyclin Dependent Kinase 1 Sales Value Share by Type (2021-2032)
5 Cyclin Dependent Kinase 1 Market by Application
  1. 5.1 Cyclin Dependent Kinase 1 Application Introduction
  2. 5.1.1 Relapsed Chronic Lymphocytic Leukemia
  3. 5.1.2 Lymphoma
  4. 5.1.3 Gliosarcoma
  5. 5.1.4 Others
  6. 5.2 Global Cyclin Dependent Kinase 1 Sales Volume by Application
  7. 5.2.1 Global Cyclin Dependent Kinase 1 Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Cyclin Dependent Kinase 1 Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Cyclin Dependent Kinase 1 Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Cyclin Dependent Kinase 1 Sales Value by Application
  11. 5.3.1 Global Cyclin Dependent Kinase 1 Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Cyclin Dependent Kinase 1 Sales Value by Application (2021-2032)
  13. 5.3.3 Global Cyclin Dependent Kinase 1 Sales Value Share by Application (2021-2032)
6 Cyclin Dependent Kinase 1 Regional Sales and Value Analysis
  1. 6.1 Global Cyclin Dependent Kinase 1 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cyclin Dependent Kinase 1 Sales by Region (2021-2032)
  3. 6.2.1 Global Cyclin Dependent Kinase 1 Sales by Region: 2021-2026
  4. 6.2.2 Global Cyclin Dependent Kinase 1 Sales by Region (2027-2032)
  5. 6.3 Global Cyclin Dependent Kinase 1 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Cyclin Dependent Kinase 1 Sales Value by Region (2021-2032)
  7. 6.4.1 Global Cyclin Dependent Kinase 1 Sales Value by Region: 2021-2026
  8. 6.4.2 Global Cyclin Dependent Kinase 1 Sales Value by Region (2027-2032)
  9. 6.5 Global Cyclin Dependent Kinase 1 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Cyclin Dependent Kinase 1 Sales Value (2021-2032)
  12. 6.6.2 North America Cyclin Dependent Kinase 1 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Cyclin Dependent Kinase 1 Sales Value (2021-2032)
  15. 6.7.2 Europe Cyclin Dependent Kinase 1 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Cyclin Dependent Kinase 1 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Cyclin Dependent Kinase 1 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Cyclin Dependent Kinase 1 Sales Value (2021-2032)
  21. 6.9.2 South America Cyclin Dependent Kinase 1 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Cyclin Dependent Kinase 1 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Cyclin Dependent Kinase 1 Sales Value Share by Country, 2025 VS 2032
7 Cyclin Dependent Kinase 1 Country-level Sales and Value Analysis
  1. 7.1 Global Cyclin Dependent Kinase 1 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cyclin Dependent Kinase 1 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Cyclin Dependent Kinase 1 Sales by Country (2021-2032)
  4. 7.3.1 Global Cyclin Dependent Kinase 1 Sales by Country (2021-2026)
  5. 7.3.2 Global Cyclin Dependent Kinase 1 Sales by Country (2027-2032)
  6. 7.4 Global Cyclin Dependent Kinase 1 Sales Value by Country (2021-2032)
  7. 7.4.1 Global Cyclin Dependent Kinase 1 Sales Value by Country (2021-2026)
  8. 7.4.2 Global Cyclin Dependent Kinase 1 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Cyclin Dependent Kinase 1 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Cyclin Dependent Kinase 1 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Cyclin Dependent Kinase 1 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Tragara Pharmaceuticals Inc
  2. 8.1.1 Tragara Pharmaceuticals Inc Company Information
  3. 8.1.2 Tragara Pharmaceuticals Inc Business Overview
  4. 8.1.3 Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product Portfolio
  6. 8.1.5 Tragara Pharmaceuticals Inc Recent Developments
  7. 8.2 Tiziana Life Sciences Plc
  8. 8.2.1 Tiziana Life Sciences Plc Company Information
  9. 8.2.2 Tiziana Life Sciences Plc Business Overview
  10. 8.2.3 Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Product Portfolio
  12. 8.2.5 Tiziana Life Sciences Plc Recent Developments
  13. 8.3 Presage Biosciences Inc
  14. 8.3.1 Presage Biosciences Inc Company Information
  15. 8.3.2 Presage Biosciences Inc Business Overview
  16. 8.3.3 Presage Biosciences Inc Cyclin Dependent Kinase 1 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Presage Biosciences Inc Cyclin Dependent Kinase 1 Product Portfolio
  18. 8.3.5 Presage Biosciences Inc Recent Developments
  19. 8.4 ChoDang Pharm Co Ltd
  20. 8.4.1 ChoDang Pharm Co Ltd Company Information
  21. 8.4.2 ChoDang Pharm Co Ltd Business Overview
  22. 8.4.3 ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Product Portfolio
  24. 8.4.5 ChoDang Pharm Co Ltd Recent Developments
  25. 8.5 Astex Pharmaceuticals Inc
  26. 8.5.1 Astex Pharmaceuticals Inc Company Information
  27. 8.5.2 Astex Pharmaceuticals Inc Business Overview
  28. 8.5.3 Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product Portfolio
  30. 8.5.5 Astex Pharmaceuticals Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cyclin Dependent Kinase 1 Value Chain Analysis
  2. 9.1.1 Cyclin Dependent Kinase 1 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cyclin Dependent Kinase 1 Sales Mode & Process
  6. 9.2 Cyclin Dependent Kinase 1 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cyclin Dependent Kinase 1 Distributors
  9. 9.2.3 Cyclin Dependent Kinase 1 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst